丹卡斯特A通过诱导氧化应激诱导前列腺癌细胞死亡
Xia Gan1, Mingyi Nie1, Siying Cai2
1Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, Nanning 530200, China; Guangxi Key Laboratory of Marine Drugs, Institute of Marine Drugs, Guangxi University of Chinese Medicine, Nanning 530200, China.
丹卡斯特A是一种真菌化合物,通过诱导氧化应激和亡,有效地杀死前列腺癌细胞. 这种天然化合物显示出作为潜在的抗前列腺癌治疗剂的希望.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氧化压力在癌症中起着复杂的作用,影响瘤的增长和细胞死亡.
- 丹卡斯特龙A是Talaromyces purpurogenu的代谢物,被确定为一种潜在的抗前列腺癌药物.
研究的目的:
- 研究Dankasterone A对前列腺癌细胞的细胞毒性作用和潜在机制.
- 在体外和体内评估Dankasterone A的抗前列腺癌潜力.
主要方法:
- 用MTT试验 (确定IC50值) 评估了细胞毒性.
- 用板克隆和实时细胞分析评估了殖民地形成和细胞迁移的抑制.
- 用流式细胞计量分析了亡诱导.
- 研究分子机制使用蛋白质微阵列,西部斑点和反应性氧物种 (ROS) 检测.
主要成果:
- 丹卡斯特A对PC-3和22Rv1前列腺癌细胞表现出显著的细胞毒性 (IC50值分别为5.10微米和3.41微米).
- 它明显抑制了克隆殖民地形成和细胞迁移.
- 丹卡斯特A诱导前列腺癌细胞的亡,而不会影响细胞周期分布.
- 该化合物上调了HO-1蛋白表达,并增加了细胞内活性氧物种 (ROS) 水平.
- 在斑马鱼异种移植瘤模型中证实了抗癌作用.
结论:
- 丹卡斯特A通过氧化应激诱导前列腺癌细胞亡,导致增殖和迁移的抑制.
- 丹卡斯特龙A证明了作为前列腺癌治疗治疗的治疗候选人的巨大潜力.
更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
09:13Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
Published on: January 5, 2024
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Intrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Drugs that Destabilize Microtubules
The Extrinsic Apoptotic Pathway
